| Parameter | Score |
|---|---|
| 1. Scale | A |
| 2. Study Population | A |
| 3. Samples | B |
| 4. Measurand | A |
| 5. Pre-Analytical | A |
| 6. Replicate Analysis | C |
| 7. Steady State | B |
| 8. Outlier Analysis | A |
| 9. Normality | B |
| 10. Variance Homogeneity | C |
| 11. ANOVA | A |
| 12. CI | C |
| 13. No of Results | A |
| 14. Concentrations | A |
| 15. Total Score | C6,10,12 |
| Comment | C6,10, 12 |
| Parameter | Score |
|---|---|
| Matrix | Unknown |
| Measurand | Cancer antigen 15-3 (CA 15.3) |
| Unit | ug / L |
| Overall Analytical Principle Method | Immunoassay; Not specified |
| Number of Subjects | 21 |
| Number of Subjects included in BV estimation | 21 |
| Ethinicity | Caucasian |
| Age Mean / Median | 50.5 |
| Age Min | 41.0 |
| Age Max | 60.0 |
| Age SD | |
| Number of Males | 0 |
| Number of Females | 21 |
| State of Well Being |
Non-healthy (excl pregnant)
|
| Diseases | |
| Study Duration Length | 6 |
| Study Duration Units | Month |
| Sampling Intervals, e.g. X sample(s) per Interval Unit | 1 |
| Interval Units | Month |
| Sampling Times | Start Time:
End Time: |
| Number of Samples | 6 |
| Average Number of Samples Used for BV Estimation | 6.0 |
| Average Number of Replicates | 2.0 |
| Estimates of CVi | 17.3 |
| Calculated Confidence Intervals of CVi | Lower: , Upper: |
| Estimates of CVg | |
| Calculated Confidence Intervals of CVg | Lower: , Upper: |
| Analytical CV | |
| Calculated Confidence Intervals of Analytical CV | Lower: , Upper: |
| Measurand Mean | |
| Measurand Min | 7.3 |
| Measurand Max | 25.7 |
| Measurand SD |